|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 | |
| G01N 33/68 | |||
| A61K 39/00 |
| (11) | Patento numeris | 3011345 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14752744.4 |
| Europos patento paraiškos padavimo data | 2014-08-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/049957 |
| Data | 2014-08-06 |
| (87) | Numeris | WO 2015/021166 |
| Data | 2015-02-12 |
| (30) | Numeris | Data | Šalis |
| 201361863299 P | 2013-08-07 | US | |
| 201361913180 P | 2013-12-06 | US |
| (72) |
MCKNIGHT, Susan Faas, US
COFIELL, Roxanne, US
KUKREJA, Anjli, US
BEDARD, Krystin, A., US
YAN, Yan, US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
100 College St., New Haven, Connecticut 06510,
US
|
| (54) | ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS |
| ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS |